Pacific Biosciences of California, Inc. (PACB) vs SS Innovations International, Inc. (SSII)
Pacific Biosciences of California, Inc. and SS Innovations International, Inc. are both Medical Devices companies. SS Innovations International, Inc. is the larger, with a market value of $591.4M against $484.9M — 1.2× the size. SS Innovations International, Inc. grew revenue faster over the last twelve months: 89.7% against 2.02%. SS Innovations International, Inc. has the higher net margin (−23.7% vs −82.5%) and the higher return on invested capital (−11.3% vs −22.2%). Across the 16 metrics below, SS Innovations International, Inc. leads on 11 and Pacific Biosciences of California, Inc. on 5.
Valuation
Profitability
| Metric | PACB | SSII | Medical Devices median |
|---|---|---|---|
| Gross margin | 36.38% | 47.65% | 56.01% |
| Operating margin | (83.53%) | (15.80%) | (15.03%) |
| Net margin | (82.49%) | (23.73%) | (20.40%) |
| Free cash flow margin | (50.53%) | (34.76%) | (7.24%) |
| Return on equity | (929.31%) | (26.06%) | (15.32%) |
| Return on assets | (16.66%) | (14.89%) | (19.72%) |
| Return on invested capital | (22.22%) | (11.31%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack